Samsung Bioepis Clinical Trial Updates | Goodwin

On December 8, Samsung Bioepis announced that it had presented the longest follow-up study results for a trastuzumab biosimilar in patients with HER2-positive early or locally advanced...

Related Keywords

United States ,American ,Samsung Bioepi ,Samsung Bioepis ,American Society Of Hematology ,Lifecycle Team Leader ,Antonio Breast Cancer Symposium ,American Society ,Annual Meeting ,Dong Hoon Shin ,Vice President ,Medical Lifecycle Team Leader ,